Sign in
Groups
Researchers
Results
HOSPITAL UNIVERSITARIO RUBER
Department
University of Nottingham
Nottingham, Reino Unido
You are in
Collaborations
University of Nottingham
Publications in collaboration with researchers from University of Nottingham (1)
2023
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
The Lancet, Vol. 401, Núm. 10371, pp. 105-117
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de